STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 100 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 2.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $11,915,000 | -52.6% | 2,461,975 | +4.1% | 0.00% | 0.0% |
| Q4 2019 | $25,140,000 | +8.4% | 2,365,074 | +6.2% | 0.00% | 0.0% |
| Q3 2019 | $23,193,000 | -21.7% | 2,228,045 | +15.2% | 0.00% | 0.0% |
| Q2 2019 | $29,620,000 | +35.9% | 1,933,455 | +14.0% | 0.00% | 0.0% |
| Q1 2019 | $21,788,000 | +73.8% | 1,695,687 | +28.5% | 0.00% | 0.0% |
| Q4 2018 | $12,536,000 | -40.9% | 1,319,596 | +3.3% | 0.00% | 0.0% |
| Q3 2018 | $21,215,000 | +4.9% | 1,278,029 | +1.5% | 0.00% | 0.0% |
| Q2 2018 | $20,215,000 | +18.9% | 1,259,542 | +13.3% | 0.00% | 0.0% |
| Q1 2018 | $17,006,000 | +14.1% | 1,111,499 | +16.4% | 0.00% | 0.0% |
| Q4 2017 | $14,902,000 | +52.5% | 955,257 | +8.5% | 0.00% | – |
| Q3 2017 | $9,775,000 | +23.0% | 880,619 | +2.0% | 0.00% | – |
| Q2 2017 | $7,946,000 | +12.6% | 863,768 | +4.7% | 0.00% | – |
| Q1 2017 | $7,055,000 | +6.2% | 825,153 | +32.9% | 0.00% | – |
| Q4 2016 | $6,644,000 | +3.2% | 620,925 | +4.4% | 0.00% | – |
| Q3 2016 | $6,440,000 | +80.6% | 594,677 | +12.9% | 0.00% | – |
| Q2 2016 | $3,566,000 | +51.0% | 526,691 | +3.9% | 0.00% | – |
| Q1 2016 | $2,362,000 | -20.4% | 506,814 | +7.8% | 0.00% | – |
| Q4 2015 | $2,967,000 | -26.7% | 470,249 | +2.6% | 0.00% | – |
| Q3 2015 | $4,047,000 | -21.1% | 458,336 | +5.2% | 0.00% | – |
| Q2 2015 | $5,127,000 | -17.4% | 435,613 | +1.6% | 0.00% | – |
| Q1 2015 | $6,207,000 | +17.8% | 428,954 | +38.9% | 0.00% | – |
| Q4 2014 | $5,269,000 | +40.8% | 308,883 | +2.8% | 0.00% | – |
| Q3 2014 | $3,743,000 | -9.0% | 300,430 | +7.1% | 0.00% | – |
| Q2 2014 | $4,114,000 | -27.1% | 280,448 | +1.2% | 0.00% | – |
| Q1 2014 | $5,642,000 | +41.3% | 277,138 | +36.0% | 0.00% | – |
| Q4 2013 | $3,993,000 | -49.4% | 203,706 | +16.8% | 0.00% | -100.0% |
| Q3 2013 | $7,897,000 | +113.0% | 174,356 | +12.1% | 0.00% | – |
| Q2 2013 | $3,707,000 | – | 155,493 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|